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ABSTRACT 
 
PHENOTYPIC SCREENING AND CHARACTERIZATION OF PROTEINS WITH 
UNKNOWN FUNCTION IN Streptococcus sanguinis SK36 
 
By Ayana Scott-Elliston, B.S. 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University. 
 
Virginia Commonwealth University  
Richmond, VA 
May 2017 
 
Principal Investigator: Dr. Peter Uetz 
Associate Professor in the Center for Biological Complexity 
 
 
 With the number of fully sequenced bacterial genomes increasing in the past 7 years, it 
has been discovered that a large percentage of the putative protein coding genes have no known 
function. This lack of knowledge leaves scientists with an incomplete understanding of bacteria. 
In this study, conserved hypothetical protein mutants from Streptococcus sanguinis SK36 were 
screened on solid media with various environmental conditions. From these screens, the 
 IX 
 
candidate protein, SSA_2372, displayed a sensitivity to acidic conditions.  Its homolog in 
Bacillus subtilis 168, BSU00030, also displayed a sensitivity to pH conditions at its acid 
tolerance extremes unlike its other homolog in Escherichia coli, YbcJ. When the growth rate and 
cell yield was acquired, the sensitivity was shown to be significant for both SSA_2372 and 
BSU00030 mutants. Through data mining, it was determined that Firmicutes in this homolog 
family COG2501 may function as a regulator for recombination protein F.
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Chapter 1  
Introduction 
I. Homology  
 
 The definition of homology is a heavily debated subject [1]. Homology has evolved with 
the increase in genomic technology and computer advancements. Its origins involved scientists 
such as Darwin and Owen, and these scientists defined homology based upon physical similarity 
between anatomical appendages and organs of different species. Currently, its study determines 
associations between organs and molecular machines based on genetics. A 
general working definition of homology that I will be using is the similarity of structure and 
function between species based on common descent.   
Today, homology is largely interwoven with phylogeny, which is the study of 
relationships in evolution. With this intersection of themes, new terminology was necessary; 
some of these terms are orthologs, paralogs, and xenologs. Orthologs are homologs that are a 
result of speciation and maintain the same function [2]. They may not have the same nucleic acid 
and amino acid sequence, but the similarity exists in its final structure and general function. 
Paralogs and xenologs are interrelated. When homology is the result of gene duplication and the 
two genes evolved together within an organism, this homolog is termed a paralog [2]. A xenolog 
is also a duplication of a gene; yet, the duplicate gene has been proven to be a gene transferred 
by horizontal or lateral gene transfer (HGT) from a different species or from a subpopulation of 
the same species [2].   
The nineteenth-century morphologist Richard Owens defined homologs as "the same 
organ in different animals under every variety of form and function" [2]. Genetic homology 
utilizes sequence, structure, and function data from previous studies to predict potential 
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homologs between species. Owen's concept of homology can be applied to bacteria, and it will 
be the utilized in this study. Specifically, I will apply the overall theme of homology based 
on Owen, but I will use the techniques of genetic homology to find connections between proteins 
[1].  
II. Uncharacterized Proteins  
 
The number of fully sequenced bacterial genomes has increased exponentially in the past 
7 years, but many of the putative proteins in these bacterial species have no known function [3]. 
Since Next Generation Sequencing (NGS) was developed, the number of fully sequenced 
genomes has increased exponentially, and we have reaped benefit from this knowledge. For 
characterized proteins, we know where in the genome they are located, which is advantageous 
for drug targeting studies of pathogenic bacteria and for the study of human-microbe interactions 
in health. For example, knowing the full sequence of prokaryotic genomes has allowed for 
techniques such as CRISPR to be found and developed, which has allowed for targeted 
mutagenesis and targeted disease treatment development.   
Unfortunately, 25% to 60% of these proteomes are composed of proteins with unknown 
function, also known as hypothetical or uncharacterized proteins [3].  Hypothetical proteins are 
proteins that are predicted to be expressed from an open reading frame, but for which there is no 
experimental evidence of translation from mRNA [4]. Based on computational analysis, these 
hypothetical proteins often fit into important functional classes, such as hydrolases, transferases, 
transporters, DNA binding proteins, and RNA binding proteins [3]. Having such a large 
proportion of proteins with unknown function creates a gap in our understanding of these 
organisms as biological systems alone and within a host system. Therefore, acquiring this 
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knowledge could help to create more efficient treatments and to prevent unnecessary secondary 
reactions that we observe in current treatments by understanding the protein pathways fully [5].   
Among hypothetical proteins, there are proteins conserved among multiple organisms 
from several phyla [4]. These proteins are called conserved hypothetical proteins and have no 
functional validation. As of October 2014, GenBank labeled 48,591,211 hypothetical sequences 
in NCBI, of which 34,064,553 were in bacteria [4]. Elucidating the function of one of these 
proteins will not only annotate its own protein/gene dataset and supplement our knowledge of the 
specific bacterium, but it will also provide functional information about its homologs.  
III. DNA   
 
A. DNA Structure and DNA Damage  
Deoxyribonucleic acid (DNA) serves as the genetic blueprint for all living creatures from 
large mammals such as homo sapiens to microscopic bacteria. DNA is composed of two 
antiparallel strands of covalently linked nucleotides [6]. Nucleotides have a nucleobase (adenine, 
thymine, guanine, or cystosine), a monosaccharide, and a phosphate group, which forms the 
covalent bond that establishes the sugar-phosphate backbone of DNA. The antiparallel strands of 
DNA associate with each other by hydrogen bonds between the nucleobases.  The 
phosphodiester bond is one of the more kinetically stable bonds found in biological functional 
groups [7]. DNA itself is stable at pH 7, and it can maintain its association in slightly alkaline 
conditions (pH 8 to 9). The presence of sodium cations helps to increase the stability of DNA by 
preventing the large negative charges of nucleophilic phosphate groups from destabilizing the 
DNA.  
Unfortunately, DNA has a susceptibility to drastic pH change, UV damage, and chemical 
damage. UV and chemical damage cause double stranded breaks [8]. At low pH, the 
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phosphodiester bonds of the DNA's sugar phosphate backbone hydrolyze, and an increase in pH 
above 9 causes the hydrolysis of the hydrogen bonds between the two antiparallel DNA 
strands [9]. Fortunately, bacteria have developed repair mechanisms to combat the effects of 
these environmental stressors.   
B. DNA Repair  
To combat environmental factors that damage DNA, such as UV damage and pH change, the 
bacterial and eukaryotic cell has developed pathways to correct double stranded DNA damage. 
Double stranded breaks are targets for exonucleases, which can lead to gene deletions, 
to incorrect DNA ends connecting, and to chromosomal rearrangements that are commonly 
present in tumors [8]. Bacteria, as well as eukaryotes, have developed two general pathways for 
repair of double stranded DNA damage, which are non homologous end joining and homologous 
recombination. Non homologous end joining (NHEJ) is the reconnection of the broken DNA 
ends by the utilization of DNA ligase and of Ku [8]. Ku is a conserved protein that binds the 
ends of the broken DNA strands to protect it from exonuclease degradation, and Ku recruits 
DNA ligase to the break site to reform the bonds [8]. The second general pathway for remedying 
double stranded DNA damage, homologous recombination, is performed for more difficult 
breaks and has multiple stages that use multiple proteins in each stage.   
Homologous recombination is composed of three stages: presynapsis, synapsis, and 
postsynapsis, and the protein groups may vary depending on the bacterial phyla [10]. 
In presynapsis, 3' single stranded DNA ends are generated to bind with the homologous sequence 
on the sister chromosome [8]. The proteins used in Escherichia coli for presynapsis is the 
enzyme complex RecBCD (recombination protein BCD), which is a multifunction protein 
complex with multiple domains [10]. Upon exposure to the Chi sequence signal 
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(5'GCTGGTGG) on dsDNA, the recombination function of RecBCD is initiated, which causes 
the enzyme to bind to DNA ends and to generate overhangs [8,10]. Synapsis presents the 3' DNA 
overhang formed by RecBCD to the homologous duplex of the sister chromosome via the 
enzyme Recombination Protein A (RecA) [8]. RecA requires ATP to bind to each ssDNA 
overhang, to create a right handed helix for inserting into the homologous duplex DNA, and to 
arbitrate annealing [8].  RecA has to be loaded onto the ssDNA due to Single Strand Binding 
proteins having a higher affinity to ssDNA than RecA [8]. The loading of RecA onto the ssDNA 
depends on the bacterial species. However, the RecFOR/FLOR pathway is conserved in many 
species for that function. The RecFOR consists of proteins recombination protein F, 
recombination protein O, and recombination protein R. For E.coli, the process is handled by one 
of two epistatic groups, RecBCD or RecFOR[8]. Bacillus subtilis has five 
epistatic groups, α (recFLOR and recN), β (addAB), γ (recP and recH) , ɛ (ruvA, recD, 
and recU),  and ζ (recS).   During the final stage of homologous recombination, postsynapsis, 
RecG and RuvA helicases generate a four stranded exchange, also known as Holliday junctions 
[8].   
IV. Acid Tolerance in Bacteria  
 Since DNA is essential to the function and propagation of all cells, the cell's ability to 
maintain the stability of its DNA is paramount. In the gut microbiome the pH can range 
drastically from 6.3 to 1.5, which is a million fold increase in the hydrogen proton concentration. 
Subsequently, the bacterial cell has developed methods to maintain its intracellular pH despite 
the drastic changes in its biome’s pH. Two examples of the bacterial cell's ability to maintain 
internal pH is E.coli and B. subtilis, neutrophiles. E.coli can maintain an internal pH range of 7.2 
to 7.8 in an extracellular pH range of 5.5 to 9, and B. subtilis, a neutrophile, can maintain a 
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constant pH of 7.4 at the pH range of 6 to 8 [11]. The protective mechanisms that allow these 
bacteria the capability to stabilize are distinguished into 2 categories XAR (extreme acid 
resistance) and ATR (acid tolerance response). ATR mechanisms are adaptive responses at 
nonlethal mildly acidic pH, such as pH 5.5 for E.coli K12, that enhances the bacteria's ability to 
handle severe acidic challenge as low as pH 3 [11]. Most bacteria possess one ATR based 
mechanism. XAR mechanisms allow cells that have not had the opportunity to acclimate to 
their acidic conditions survive at pH conditions less than 2.5 [11]. An environment with such an 
extreme high concentration of protons produces a biome that does not permit the growth 
of neutrophilic bacteria.  
VI. Streptococcus sanguinis  
 The oral ecosystem is a complex biome. The temperature is maintained around 35°C - 36 
°C, except in inflammation induced conditions where it increases to 39 °C [12].  The majority of 
the bacterial species in the mouth are facultative anaerobes or obligate anaerobes, yet there is a 
small population of aerobes in the oral cavity [12]. The difference between the two types of 
anaerobes is that facultative anaerobes can exist with or without oxygen present, where obligate 
anaerobes cannot exist with oxygen. These oral microflora proliferate in distinct regions of the 
mouth depending on their capability of handling various percentages of oxygen [12]. The most 
anterior portion of the mouth is exposed to ~20% O2, and the most posterior buccal folds is 
~0.3%. Additionally, the oral cavity ranges distinctly in pH over time and in different regions, 
which its inhabitants need to handle. A healthy mouth’s pH lies between 6.5 to 6.9 at rest, and as 
a mouth is stimulated while eating its pH increases to between 7.0 to 7.5 [12]. The maintenance 
of this pH is handled on regions of the mouth by saliva [12]. An individual with poor oral health 
and dental caries tends to have a more acidic pH in their mouth. Normally, after the consumption 
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of foods high in carbohydrates, the catabolism of sugars by the bacteria will decrease the pH. 
However, the pH will return gradually to resting conditions [12]. The bacteria associated with 
good oral health can handle brief instances of high concentrations of hydrogen protons, but the 
bacteria associated with dental caries thrive in acidic conditions for a prolonged period of time. 
 One of these healthy oral microbes is Streptococcus sanguinis. It is a facultative 
anaerobe, and its pH growth range in the mouth under normal conditions is from 5.0 to 7.8. S. 
sanguinis inhibits the growth of bacteria involved in dental caries, e.g. Streptococcus mutans by 
the release of hydrogen peroxide - an end product of its metabolism [12]. 
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VII. Research Objective  
The Aims of this Study are: 
1. To phenotypically screen conserved uncharacterized proteins of Streptococcus 
sanguinis SK36   
2.  To find a single protein without paralog that displays a phenotype to one of the 
environmental conditions  
3. To study the protein using bioinformatics, systems biology, and molecular biology to 
potentially elucidate its function.   
The overall objective of this study is to investigate and to characterize a conserved 
uncharacterized protein family to help in the effort of closing our gap in knowledge of bacterial 
proteins.  
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Chapter 2 
Materials and Methods 
Bacterial Culture Conditions.  The Streptococcus sanguinis SK36 wild type and its mutants 
used in this study were created and provided by the Ping Xu Lab [13]. They are listed in Table 1. 
S. sanguinis SK36 and its mutants were revived from 80% glycerol freezer samples in Brain 
Heart Infusion Broth (BD Difco) broth under microaerophilic conditions (7 – 10% CO2 and 6% 
O2) at 37 °C in an AnaeroPack 2.5 L Rectangular Jar (Thermo Scientific). For all experiments, S. 
sanguinis SK36 and its mutants were grown in microaerophilic conditions (7 – 10% CO2 and 6% 
O2) at 37 °C.  
B. subtilis 168 and E.coli K-12 wild type and mutants used in this study are listed in 
Table 2. B. subtilis 00030 mutant was provided by the Bacillus Genetic Stock Center, and E.coli 
ybcJ mutant and oxaC control strain was provided by the Osterman lab at  Sanford Burnham 
Prebys Medical Discovery Institute. The Bacillus subtilis 168 WT,  B. subtilis 168 00030 mutant, 
Eschericihia coli K-12 WT, and E. coli K-12 ybcJ mutant were revived in LB broth in aerobic 
conditions with 1 ug/mL erythromycin (B. subtilis) and 1 ug/mL kanamycin (E.coli). 
 
Broth Preparation: Brain Heart Infusion. 37 grams of BHI powder was dissolved in 1000mL 
deionized H2O using a stir bar and heating at 100 °C on a hot plate. It was then autoclaved for 15 
minutes at 121°C. The sealed autoclaved broth was stored at 4 °C when not in use.  
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Broth Preparation: pH specific BHI media. 37g of BHI powder was dissolved in 1000mL 
deionized H2O using a stir bar and heating at 100 °C. The dissolved BHI broth was adjusted to 
the following pH values depending on the experiment: 4, 5, 5.5, 6, 6.5, 7, 8, & 10. The pH 
adjustments to create the acidic pH values were achieved by pipetting 12.1 M hydrochloric acid 
until the broth reached the appropriate value. The alkaline pH values were reached by pipetting 
volumes of 0.0316M NaOH (pH 12.5) into the BHI broth and mixing after each addition. When 
the BHI was at the appropriate value, the Erlenmeyer flasks were autoclaved for 15 minutes at 
121°C. 
 
Agar Preparation: pH specific BHI plates. 52g of BHI agar powder was dissolved in 1000mL 
deionized H2O using a stir bar and heating at 100 °C. The dissolved BHI broth was adjusted to 
the following pH values depending on the experiment: 4, 5, 5.5, 6, 6.5, 7, 8, & 10. The pH 
adjustments to create the acidic pH values  was achieved by pipetting 12.1 M hydrochloric acid 
until the broth reached the appropriate value. The alkaline pH values were reached by pipetting 
volumes of 0.0316M NaOH (pH 12.5) into the BHI broth and mixing after each addition. When 
the BHI was at the appropriate value, the Erlenmeyer flasks were autoclaved for 15 minutes at 
121°C. When the Erlenmeyer flasks reached 70 °C, the molten agar was poured into omnitrays. 
Once the plate solidified, it was stored in sterile containers in a cold room until used.  
 
Agar Preparation: Chemically Defined Media with Various Sugars. All of the values of the 
Chemically Defined Media used in Ping Xu’s study had to be doubled because it would be 
diluted in half when the agar was introduced [13]. For every 1000 mL deionized H2O, 20g of 
selected sugar, 4.0 g of L-glutamic acid, 0.4 g of L-cysteine, 1.8 g of L-leucine, 2.0 g of NH4Cl, 
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5.0 g of K2HPO4, 5.0 g of KH2PO4, 8.0 g of NaHCO3, 2.4 g of MgSO4.7H2O, 0.04 g of 
MnCl2.4H2O, 0.04 g of FeSO4.7H2O, 1.2 g of sodium pyruvate, 2.0 mg of riboflavin, 1.0 mg of 
thiamine HCl, 0.2 mg of D-biotin, 2.0 mg of nicotinic acid, 0.2 mg of p-aminobenzoic acid, 1.0 
mg of Ca-pantothenate, 2.0 mg of pyridoxal HCl, 0.2 mg of folic acid, and adjusted to pH 7.0 
with H3PO4. In order to add the sugar, riboflavin, thiamine HCl, D-biotin, nicotinic acid, p-
aminobenzoic acid, Ca-pantothenate, pyridoxal HCl, and folic acid, a stock solution of each was 
created with dH2O. Then, the appropriate volume from each stock solution was added to the 
1000 mL solution. Once all of chemicals were added, the solution was filter sterilized with 
Stericup filter bottle Units (Millipore).  The selected sugars were glucose, mannose, galactose, 
and lactose. The agar was made by adding 15g of agar to 1000mL dH2O, which was autoclaved 
at 121 °C for 15 minutes. The agar was cooled in a hot water bath to 55 °C, which is lower than 
the 60 °C degradation temp for the vitamins and the minimum temperature to maintain the liquid 
phase of agar without bubbles.  
 
Phenotype Screen: Solid Phase. Following the revival of the strains in a 96 well microtiter 
plate, these mutants were pinned to the respective agar plate using a pin tool attached to the 
Biomek FX robot (Beckman Coulter). The motion of the pin tool followed the respective 
program I designed, and between pinning a new plate, it always included a four-step wash 
process – a dH2O rinse, a 10 second ethanol soak, a 30 second 10% bleach soak, and a final 
dH2O rinse. These plates were incubated for 48 hours in an Anoxomat jar (Spiral Biotech) in 
which the microaerophilic conditions were generated by the Anoxomat system (Mart). 
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Quantification of Phenotype: Liquid Phase. 200µL of the BHI broth of a specific pH value 
was added to the appropriate column in a black 96 well plate. For the S. sanguinis SK36 mutant 
phenotype quantification, the wells were inoculated from an overnight growth by the pintool of 
the Biomek FX robot. For the E.coli and B. subtilis strains phenotype quantification, the wells 
were inoculated with 1 µL from an overnight growth. For both quantification studies, the source 
plate mutants had an OD of 0.9 to 1.0 at 600 nm. The inoculum was grown overnight at 37 °C 
with atmospheric conditions of 6% O2 and 6% CO2 in the BioTek Synergy H1 Hybrid Multi-
Mode Monochromator Fluorescence Microplate Reader (BioTek). Readings were taken every 
ten minutes at 600nm. 
 
Bioinformatics. The sequence analysis and homolog search was performed using NCBI Protein 
Blast non redundant protein sequences database; homolog determination was also performed via 
Eggnog v 4.5.1 and UNIPROT  [14,27].  The comparative multiple sequence alignment of the 
COG2501 homologs were performed with ClustalOmega version 1.2.1 [15]. The visualization of 
the phylogenetic tree data was created using the interactive Tree of Life (iTOL) version 3.5, and 
the code utilized to separate the species from EGGNOG into families with stars was created by 
Harry Caufield [16]. Protein abundance data was extracted on COG2501 from PaxDB version 
4.0 [17]. The source of the data was either presented in the file extracted from the website, or it 
was acquired by contacting the PaxDB curators [17]. Hypothetical COG2501 structures and 
secondary structure information was calculated by I-Tasser version 5.1 and RaptorX [18,19, 20, 
21]. The NCBI taxonomy database was utilized for information on phyla [22], and the Microbial 
Genome Context Viewer (MGcV) was used to visualize the genome context for all proteins in 
this study [29]. 
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Statistics, Growth Rate, & Doubling Time Calculations. 
All statistical tests were performed utilizing R and R Studio [23,24]. The necessary packages for 
these statistical tests were stats version 3.3.2, methods version 3.3.2, datasets version 3.3.2, and 
utils version 3.3.2.  The R code used is in the Supplemental (Supplemental Table 2). Exponential 
growth rate is a first order reaction, and the equation used to calculate the growth rates and 
doubling times are below. In the growth rate equation, t represents time, and c represents the 
optical density obtained at 600nm. 
K = growth rate = ln (Cf/Ci) 
          (tf – ti) 
t2/1 = doubling time = ln (2) 
   k 
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Table 1: S. sanguinis strain and its mutants without paralogs used in this study 
Conserved hypothetical 
protein mutants  
Mutation Species 
Count 
SK36 wildtype   
SSX_0064 SSA_0064 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 157 
SSX_0066 SSA_0066 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 217 
SSX_0073 SSA_0073 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 280 
SSX_0101 SSA_0101 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 530 
SSX_0152 SSA_0152 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 7 
SSX_0161 SSA_0161 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 15 
SSX_0183 SSA_0183 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 67 
SSX_0188 SSA_0188 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 582 
SSX_0224 SSA_0224 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 23 
SSX_0238 SSA_0238 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 66 
SSX_0252 SSA_0252 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 26 
SSX_0273 SSA_0273 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 9 
SSX_0274 SSA_0274 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 120 
SSX_0281 SSA_0281 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 13 
SSX_0288 SSA_0288 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 2 
SSX_0293 SSA_0293 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1073 
SSX_0299 SSA_0299 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 376 
SSX_0305 SSA_0305 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 77 
SSX_0311 SSA_0311 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 186 
SSX_0316 SSA_0316 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 917 
SSX_0339 SSA_0339 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 284 
SSX_0341 SSA_0341 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 507 
SSX_0353 SSA_0353 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 74 
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SSX_0354 SSA_0354 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 62 
SSX_0390 SSA_0390 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 142 
SSX_0431 SSA_0431 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 256 
SSX_0446 SSA_0446 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 117 
SSX_0505 SSA_0505 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 70 
SSX_0591 SSA_0591 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 312 
SSX_0595 SSA_0595 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 540 
SSX_0624 SSA_0624 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1499 
SSX_0627 SSA_0627 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 182 
SSX_0629 SSA_0629 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 239 
SSX_0646 SSA_0646 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 96 
SSX_0647 SSA_0647 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 157 
SSX_0659 SSA_0659 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 438 
SSX_0664 SSA_0664 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 79 
SSX_0668 SSA_0668 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 205 
SSX_0670 SSA_0670 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 89 
SSX_0672 SSA_0672 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1599 
SSX_0711 SSA_0711 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 411 
SSX_0752 SSA_0752 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 692 
SSX_0755 SSA_0755 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 121 
SSX_0802 SSA_0802 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 749 
SSX_0803 SSA_0803 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 130 
SSX_0815 SSA_0815 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 323 
SSX_0843 SSA_0843 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 664 
SSX_0844 SSA_0844 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 93 
SSX_0864 SSA_0864 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 464 
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SSX_0868 SSA_0868 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1303 
SSX_0874 SSA_0874 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 736 
SSX_0885 SSA_0885 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 108 
SSX_0915 SSA_0915 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 58 
SSX_0978 SSA_0978 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 169 
SSX_0983 SSA_0983 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 55 
SSX_0985 SSA_0985 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 108 
SSX_0990 SSA_0990 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 114 
SSX_0992 SSA_0992 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 77 
SSX_1067 SSA_1067 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 64 
SSX_1076 SSA_1076 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 321 
SSX_1078 SSA_1078 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 121 
SSX_1083 SSA_1083 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 
75 
SSX_1154 SSA_1154 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 996 
SSX_1156 SSA_1156 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 80 
SSX_1161 SSA_1161 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 173 
SSX_1180 SSA_1180 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 139 
SSX_1201 SSA_1201 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1506 
SSX_1203 SSA_1203 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 200 
SSX_1211 SSA_1211 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 136 
SSX_1214 SSA_1214 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 109 
SSX_1238 SSA_1238 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 95 
SSX_1247 SSA_1247 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 80 
SSX_1248 SSA_1248 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 74 
SSX_1249 SSA_1249 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 95 
SSX_1280 SSA_1280 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 341 
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SSX_1313 SSA_1313 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 191 
SSX_1348 SSA_1348 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 78 
SSX_1353 SSA_1353 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 303 
SSX_1384 SSA_1384 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 78 
SSX_1404 SSA_1404 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 59 
SSX_1418 SSA_1418 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 495 
SSX_1439 SSA_1439 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 932 
SSX_1454 SSA_1454 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 60 
SSX_1455 SSA_1455 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 215 
SSX_1471 SSA_1471 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 729 
SSX_1480 SSA_1480 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 256 
SSX_1526 SSA_1526 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 360 
SSX_1535 SSA_1535 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 66 
SSX_1537 SSA_1537 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 177 
SSX_1540 SSA_1540 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 67 
SSX_1545 SSA_1545 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 112 
SSX_1549 SSA_1549 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method  302 
SSX_1554 SSA_1554 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 83 
SSX_1562 SSA_1562 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 552 
SSX_1585 SSA_1585 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 343 
SSX_1586 SSA_1586 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 327 
SSX_1587 SSA_1587 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 338 
SSX_1610 SSA_1610 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 149 
SSX_1618 SSA_1618 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 594 
SSX_1627 SSA_1627 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 302 
SSX_1646 SSA_1646 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 226 
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SSX_1651 SSA_1651 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 69 
SSX_1686 SSA_1686 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 129 
SSX_1704 SSA_1704 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 137 
SSX_1707 SSA_1707 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 75 
SSX_1746 SSA_1746 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 51 
SSX_1765 SSA_1765 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 94 
SSX_1770 SSA_1770 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 593 
SSX_1772 SSA_1772 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 169 
SSX_1786 SSA_1786 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 207 
SSX_1808 SSA_1808 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 83 
SSX_1817 SSA_1817 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 98 
SSX_1833 SSA_1833 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 47 
SSX_1837 SSA_1837 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1126 
SSX_1844 SSA_1844 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 98 
SSX_1855 SSA_1855 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 998 
SSX_1899 SSA_1899 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 404 
SSX_1910 SSA_1910 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 346 
SSX_1911 SSA_1911 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1076 
SSX_1921 SSA_1921 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 53 
SSX_1941 SSA_1941 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 234 
SSX_1960 SSA_1960 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 92 
SSX_1981 SSA_1981 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 75 
SSX_1987 SSA_1987 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 176 
SSX_2000 SSA_2000 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 85 
SSX_2013 SSA_2013 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 118 
SSX_2021 SSA_2021 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 69 
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SSX_2030 SSA_2030 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1272 
SSX_2036 SSA_2036 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 241 
SSX_2038 SSA_2038 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 150 
SSX_2076 SSA_2076 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 139 
SSX_2126 SSA_2126 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1653 
SSX_2170 SSA_2170 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 278 
SSX_2188 SSA_2188 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 361 
SSX_2189 SSA_2189 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 269 
SSX_2198 SSA_2198 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 52 
SSX_2252 SSA_2252 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 218 
SSX_2337 SSA_2337 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 78 
SSX_2340 SSA_2340 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 130 
SSX_2354 SSA_2354 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 283 
SSX_2369 SSA_2369 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 277 
SSX_2372 SSA_2372 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 184 
SSX_2386 SSA_2386 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 52 
SSX_2390 SSA_2390 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 377 
SSX_2390 SSA_2390 replaced with aphA- 3 gene encoding kanamycin 
resistance using recombinant PCR method 1653 
 
 
Table 2: B.subtilis & E.coli strains and COG2501 homologs used in this study. 
Bacterial Strain Strain Mutant 
B. Subtilis 168 yaaA, BKE00030 
E. coli  K-12  ybcJ, b0528, JW5070 
E. coli K-12 uxaC 
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Chapter 3 
Environmental Based Screening of 149 S. sanguinis SK36 mutants & the 
Candidate Proteins that were Found 
Identification of Candidate Protein 
 The qualitative rate of growth of 147 S. sanguinis SK36 mutants in different pH 
conditions (pH 5.8, pH 6, pH 7, pH 8, & pH 10) was analyzed based on the diameter of the 
inoculation pin on BHI agar. All of the selected mutants grew with diameters the size of the pins 
at pH 7, which was our pH control for growth (Figure S1). At slightly acidic pH of 6, the mutant 
in row D column 9, SSX_2372, had diminished growth (Figure 1). When you zoom into row D, 
you can see the mutants in columns 1 to 8 have full pins in which you unable to distinguish 
individual colonies from the pin (Figure 2).  SSX_2372 was not affected by a change in carbon 
source, and it grew the same with glucose, mannose, lactose and galactose (Figure 3, 4, 5, 6). All 
colonies grew to the same size (Figure 3, 4, 5, 6).  
To get a clearer visual comparison of the two candidate proteins SSA_2372 & 
SSA_1480, the two candidate proteins were pinned to agar alongside the wildtype and two pH 
control mutants, SSX_0204 and SSX_1507 (Figure 7). These pH control mutants were identified 
in previous studies by the Xu lab. SSX_0204 has an acid resistant phenotype, and SSX_1507 is 
acid sensitive. At pH 7, SSX_1507 has a diminished diameter of its inoculation pin, and its 
individual colonies are visible (Figure 7). SSX_1507 has no growth at pH 7 (Figure 7). These 
mutants were discovered to have these phenotypes in Dr. Ping Xu’s lab [13]. When compared to 
S. sanguinis SK36 pH control mutants, SSX_2372 has pronounced pH phenotype (Figure 7). 
SSX_2372 at pH 6 looks like SSX_1507 does at pH 7 (Figure 7). You can see individual 
colonies, and the diameter of the inoculation pin is smaller (Figure 7).  
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Figure 1. BHI Agar Plate (pH6) Pinned with Streptococcus sanguinis SK36 mutants. On 
these two plates, 95 mutants were pinned in quadruplicate, and the plate was incubated at 37 °C 
under microaerophilic conditions for 48 hours. The dotted box indicates the wells with extreme 
diminished growth.  
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Figure 2. BHI Agar Plate (pH 6) Pinned with Streptococcus sanguinis SK36 mutants Zoom 
Into Candidate Protein, SSA_2372. On these two plates, 95 mutants were pinned in 
quadruplicate, and the plate was incubated at 37 °C under microaerophilic conditions for 48 
hours. Row D was enlarged to make the well, D9, that displayed the acid sensitivity clear.  
 
 
 
 
 
 
 
 
 
 23 
 
 
Figure 3. Chemically Defined Agar with Glucose. This plate contains the minimal amount of 
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for 
this plate is glucose. It was grown at 37 °C for 48 hours under microaerophilic conditions.  
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Figure 4. Chemically Defined Agar with Lactose. This plate contains the minimal amount of 
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for 
this plate is lactose. It was grown at 37 °C for 48 hours under microaerophilic conditions. 
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Figure 5. Chemically Defined Agar with Mannose. This plate contains the minimal amount of 
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for 
this plate is mannose. It was grown at 37 °C for 48 hours under microaerophilic conditions. 
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Figure 6. Chemically Defined Agar with Galactose. This plate contains the minimal amount of 
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for 
this plate is galactose. It was grown at 37 °C for 48 hours under microaerophilic conditions.  
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Figure 7. Qualitative Comparison at pH 6 and pH 7 of Streptococcus sanguinis SK 36 
candidate mutants and control mutants on BHI Agar. The plates were pinned using a Biomek 
FX with a pin plate in quadruplicate for each mutant in BHI agar at pH 7 and pH 6. These plates 
were grown at 37 °C under microaerophilic conditions. 
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Quantification of Phenotype 
 The candidate proteins’ cell yield was quantified and compared using optical density in a 
96 well plate at pH 4, pH 5.8, pH 6, pH 7, pH8, and pH 10 in BHI broth (Figure 8). The doubling 
time of S. sanguinis SK36 wildtype is approximately 1 hr 11 minutes under microaerophilic 
conditions at pH 7, and it has a growth rate of 0.58 doublings per hour.  At pH 6, S. sanguinis 
SK36 wildtype has a doubling time of 3 hours and 10 minutes. The acid sensitive control mutant, 
SSX_1507, grew the least at pH 7 as expected based on its growth on the agar, and it had 
negligible growth at pH 6 (Figure 8). The doubling time of SSX_1507 at pH 7 is approximately 1 
hour 41 minutes, and its growth rate is 0.4 doublings per hour. The doubling time of SSX_1507 
at pH 6 was 0.076 doublings per hour, and it had a doubling time of approximately 9 hours. 
SSX_1507’s cell yield and growth rate are significantly different at a p value of 0.01 and 0.05 at 
both pH 6 and pH 7 than the wildtype of S. sanguinis SK36, which makes it a good acid sensitive 
control. The candidate mutant, SSX_2372, has a cell yield that is significantly smaller compared 
to the wildtype at confidence level of 95% and 99% at pH 7 and pH 6. SSX_2372 has a growth 
rate of 0.16 doublings per hour and a doubling time of approximately 4 hours and 18 minutes.  
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Figure 8. Growth Curves of the S. sanguinis SK36 candidate mutants and control mutants 
in BHI broth at pH 7 and pH 6. 96 well plates were inoculated in pH specific media, and it was 
grown overnight under microaerophilic conditions. Optical density readings at 600nm were 
recorded every 10 minutes. 
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Chapter 4 
Bioinformatic Characterization of S. sanguinis SSA_2372 Protein & the 
Analysis of its Conserved Orthologous Group, COG2501 
 
Conservation of COG2501 
 The conservation of this candidate protein was determined utilizing bioinformatics 
databases. COG2501 can be found in 776 species of bacteria (16 ). Homologs of SSA_2372 can 
be found in 5 major phyla and 2 superphyla (Figure 9). The phyla include Proteobacteria, 
Firmicutes, Actinobacteria, Cyanobacteria, and Fusobacteria, and the superphyla include PVC 
group and FCB Group (Figure 9). Homologs of COG2501 in the PVC superphyla can be found 
in Ilyobacter (order), unclassified Verrucomicrobiales (order), and Planctomycetaceae (family), 
and in the FCB group they are found in Flavobacteriales (order) and Sphingobacteriales (order) 
(Figure 9). Homologs are not found in the phyla of Chlamydiae, Thermodesulfobacteria, 
Acidobacteria, Thermotogae, and Spirochaetes, and Chloroflexi (Figure 9). In the phyla, 
homologs are found in 33 families of Firmicutes, 85 families of Proteobacteria, 26 families of 
Actinobacteria, and 2 families and 3 orders of Cyanobacteria.  
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Figure 9. Phylogenetic Tree displaying the conservation of COG2501 at the phyla and 
superphyla level. Homolog list with NCBI identifiers was extracted from the EGGNOG 
database, and the dataset was inputted into iTOL v3.5 for phylogenetic tree visualization.  
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Functional Annotation, Expression, and Structural Prediction of SSA_2372 
 In depth data mining and utilization of structural genome prediction software was 
performed to gather functional and structural information on this gene/protein family. Based on 
NCBI protein blast comparisons and other various protein comparison software, SSA_2372 has 
been established as having an S4 domain (Table 3) [25]. It has two domains: a conserved 
domain, S4, and a coil-coil domain. The S4 domain is approximately 64 AA in length, and it is 
predicted to be comprised of 3 alpha helices and 5 beta sheets (Table 3). The S4 domain is also a 
part of a well conserved domain family [25]. The coil-coil domain is a non-conserved domain 
family, and it is predicted to be composed of alpha helices in a scissor shape. The RaptorX 
structure prediction, which is a software that predicts structure on sequence alone, has 3 alpha 
helices and 5 beta sheets (Figure 10) [20]. I-Tasser, which utilizes both sequence and crystal 
structures from homologs, also has 3 also has 3 alpha helices and 5 beta sheets (Figure 12). In 
RaptorX, the coil-coil domain, curls towards the other domain forming a pocket (Figure 11). 
However, in I-Tasser, the coil-coil domain extends away from the S4 domain (Figure 12).  
 The protein expression level of COG2501 depends on the species. The Streptococcus 
pyogenes homolog (Firmicute), SPY_2203, expresses under normal BHI conditions at 5.11 ppm 
and 9.69 ppm (Table 4).  When the growth media is supplemented with 0.3% yeast, it expresses 
at a slightly higher value of 31.5 ppm (Table 6). When compared to the expression of all proteins 
in S. pyogenes, it is in the bottom 10% to 25% (Table 4). The E.coli homolog (Proteobacteria) 
YbcJ, expresses under various growth conditions in the top 25%. Some of the abundance values 
are 805 ppm, 617 ppm, and 352 ppm (Table 4). 
Genomic Context and Sequence Comparison of COG2501 
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COG2501 varies both in sequence similarity and in size from a single domain protein 
approximately 68 AA to 80 AA in length to a two-domain protein approximately 130 to 140 AA 
in length (Figure 10, 13, 14). In all species of the genus Streptococcus, COG2501 has two 
domains and is approximately 130 AA in length. In all homologs in the genus Lactococcus, 
COG2501 also has two domains and is ~130 AA in length (Figure 10). In Bacillus homologs 
such as B. subtilis, the protein only has a single domain and is 70 AA in length, which is the S4 
domain (Figure 10). B. subtilis has a sequence similarity of ~60% (Figure 13). For all other 
homologs such E. coli and V. cholera, the protein is ~70 AA in length with the single predicted 
S4 domain (Figure 10). E.coli has a sequence similarity of ~ 20% (Figure 14). The 
Streptococcus, Lactococcus, and Bacillus genus is in the Firmicutes phyla, and E.coli is in 
Proteobacteria [22].  
Interactions of COG2501 
 The interactions of COG2501 family of proteins depends on the species. In E.coli, YbcJ 
interacts with the subunits of the ribosome, 30S ribosomal proteins and 50S ribosomal proteins, 
but not the polysome (26). This data was determined by pull down assays and immunoblot 
analysis [25, 28]. These ribosomal subunits include: 30S ribosomal protein S6, 30S ribosomal 
protein S2, 30S ribosomal protein S3, 50S ribosomal protein L1, 50S ribosomal protein L7/L12, 
50S ribosomal protein L9, 50S ribosomal protein L11, 50S ribosomal protein L19, 50S 
ribosomal protein L20, and 50S ribosomal protein L33 (Table 4). ybcJ also interacts with 
metabolic enzymes and degradation proteins. It interacts with Pnp-polyribonucleotide 
nucleotidyltransferase, aceF- dihydrolipoyllsine-residue acetytyltransferase component of 
pyruvate dehydrogenase complex, dnaJ- chaperone protein DnaJ, and Eno – alpha-enolase 
(Table 4). Pnp is involved in mRNA degradation and tRNA processing; it catalyzes the 
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phosphoroylsis of ss polyribonulceotides in the 3’ to 5’ direction and works with RNase II (Table 
4). AceF catalyzes the conversion of pyruvate to acetyl-CoA and oxygen, and DnaJ works with 2 
other proteins to disaggregate stress-denatured and unfolded proteins [27]. The S. pneumoniae 
homolog, SP_2226, was found to interact by Y2H in the Uetz lab with SP_0064 - PTS system 
IIA component – and by microfluidics with SP_2227 – recombination protein F. 
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Table 3. Annotation of SSA_2372 from NCBI & UNIPROT. 
SSA_2372 Annotation 
Sequence MEYKLFDDYITLQALLKETGIIQSGGAIKTFLSEYPVLFNGEPENRRGKKLR
VNDRISLPEQGIEINLTAPSQEEILQHQKEIAEKKRVAELVKAMNKDLKKSQ
TSKKEKRKNTGIPKKQKTTKSPVRFPGI 
Domains S4 Domain Coil-coil 
 Approximately 64 AA in length Approximately 30 AA in length 
 3 alpha helices and 5 beta sheets Alpha helices in scissor shape 
 Conserved domain Non-conserved domain 
EGGNOG COG2501  
NCBI YP_001036279.1  
UNIPROT A3CRC4  
No identical proteins outside of Streptococcus sanguinis 
Found in all sequenced strains of Streptococcus sanguinis 
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Figure 10. Structural rendering of SSA_2372 using RaptorX. RaptorX developed this 3-D 
rendering based on the sequence alone using its in house developed software. 
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Figure 11. Structural rendering of SSA_2372 using iTasser. iTasser developed this 3-D 
rendering for SSA_2372 using it sequence and homolog modeling. In the S4 protien family, 
there currently are only 3 crystal structures in PDB: ybcJ, S4, and tyrosyl-tRNA synthetase.  
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Figure 12. Genomic context of SSA_2372 and its homologs created using MgCV. NCBI 
locus tags were extracted from UNIPROT and EGGNOG, and these locus tags were used in 
MGcV to visualize SSA_2372 and COG2501 homologs in the context of their position in their 
respective genomes. SSA_2372 and the COG2501 homologs are framed in red.  
 39 
 
 
 
Figure 13. Sequence alignment of SSA_2372 of S. sanguinis and yAAA of B.subtilis.  The 
sequences were acquired from NCBI, and the sequence comparison was done using ClustalW.  
 
 
 
 
 
 
 
Figure 14. Sequence alignment of SSA_2372 of S. sanguinis and ybcJ of E. coli. The 
sequences were acquired from NCBI, and the sequence comparison was done using ClustalW. 
 
 40 
 
Table 4. Annotation of SSA_2372 from NCBI & UNIPROT. 
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Table 5. Experimentally Confirmed Interactions of SSA_2372 Firmicute homologs: 
SP_2226, (S. pneumoniae), SP_2100 (S. pneumoniae), and BSU11620 (B. subtilis) 
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Table 6. Protein Abundance of COG2501 homologs extracted from PaxDB. 
Protein Abundance 
Gene 
Name 
PPM Percentage in the Entire Proteome of 
that extraction 
ybcJ 805 ppm Top 25% 
 617 ppm Top 25% 
 352 ppm Top 25% 
 331 ppm Top 25% 
Spy_2203 5.11 ppm Bottom 10% 
 9.69 ppm Bottom 10% 
 31.5 ppm Bottom 25% 
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Chapter 5 
Phenotype Comparison of 2 homologs of SSA_2372: BSU00030 in B. subtilis 
and ybcJ in E.coli 
 
 To determine if the acid sensitivity phenotype was SSA_2372 specific, strains with 
mutations in two homologs, YbcJ and BSU00030, were grown in pH increments of 0.5 within 
the range of pH 5 – 8. At pH 7 and pH 6, BSU00030 had no significant difference in growth rate 
or cell yield to the B. subtilis WT (Figure 15). However at pH 5.5 and pH 5, BSU00030’s cell 
yield was significantly different from B.subtilis WT (Figure 16). In the cases where the mutant 
was significantly different from the WT, it was the mutant that had significantly smaller cell 
yield. E. coli had different results. There was no significant difference at pH 7 between the 
control and the YbcJ mutant (Figure 17). At pH 6, there was a significant difference between 
control and YbcJ mutant, but in this case it was the control E.coli mutant, oxaC gene knockout, 
that had a significantly smaller cell yield compared to the COG2501 homolog, YbcJ. At pH 5, 
however, there was no significant difference between the YbcJ mutant and the control mutant in 
cell yield or growth rate (Figure 18).  
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Figure 15. Quantification of Acid Tolerance Phenotype in B. subtilis WT and BSU00030 at 
pH 6 and 7. 96 well black walled plates had media containing BHI media of the following pH 
range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at 600nm of the WT and 
BSU00030 was recorded every 10 minutes for 20 hours. This graph shows the comparison of the 
growth values at pH 7 and pH 6. With a 95% confidence level, the p-value for a two sided t-test 
between the WT and the mutant at pH 6 is 0.899, which is not significant. 
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Figure 16. Quantification of Acid Tolerance Phenotype in B. subtilis WT and BSU00030 at 
pH 5 and 7. 96 well black walled plates had media containing BHI media of the following pH 
range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at 600nm of the WT and 
respective mutant was recorded every 10 minutes for 20 hours. This graph shows the comparison 
of the growth values at pH 7 and pH 5. With a 95% confidence level, the p-value for a two sided 
t-test of the WT and mutant at pH 5 is 5E-9, which is significant. 
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Figure 17. Quantification of Acid Tolerance Phenotype in E.coli oxaC kanamycin cassette 
control and ybcJ at pH 6 and 7. 96 well black walled plates had media containing BHI media 
of the following pH range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at 
600nm of the WT and respective mutant was recorded every 10 minutes for 20 hours. This graph 
shows the comparison of the growth values at pH 7 and pH 6. With a 95% confidence level, the 
p-value for a two sided t-test between the control and the mutant at pH 6 is 0.002968, which is 
significant. 
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Figure 18. Quantification of Acid Tolerance Phenotype in E.coli oxaC kanamycin casette 
control and ybcJ at pH 5 and 7. 96 well black walled plates had media containing BHI media 
of the following pH range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at 
600nm of the WT and respective mutant was recorded every 10 minutes for 20 hours. This graph 
shows the comparison of the growth values at pH 7 and pH 5. With a 95% confidence level, the 
p-value for a two sided t-test between the control and the mutant at pH 5 is 0.2896, which is not 
significant. 
 
 
 
 
 
 48 
 
Chapter 6 
Discussion 
 
Screening mutants based on phenotypic features provides pertinent information that can 
be immediately annotated to its COG or ENOG; however, if you desire perspective on the 
bacteria's behavior in its natural environment, you must select your phenotype choice carefully. 
For our phenotypic screens, I selected different pH ranges and sugars as the natural biome of S. 
sanguinis SK36 is the mouth, which is exposed to different metabolites and pH ranges regularly. 
With these two types of screens, we could easily detect the impact to the mutants, and draw 
relevant conclusions. In the oral microbiome, pH decreases as a result of the metabolism of the 
native bacteria; it will also vary due to the pH of the items consumed, whether being acidic or 
alkaline. An individual's diet, which depending on your geographic region can be very specific, 
dictates the exposure to simple sugars that your oral microbiome experiences. For example, we 
used mannose as one of the screening sugars, which can be found in tomatoes, apples, oranges, 
and cranberries. If these foods aren't common in your environment, your bacteria may not have 
developed a pathway to process it, or it may exist as a non-essential pathway that was developed 
in early homo sapiens. In the case of the study, we found more than one mutant that showed 
susceptibility to low pH, such as SSA_1480, but none other with such a strong phenotype to low 
pH as SSA_2372. The decision to focus on SSA_2372, otherwise known as COG2501, was 
because the gene is conserved within multiple strains of S. sanguinis; it has a GC content similar 
to most of its genome, demonstrating that it was not horizontally transferred; and because it is a 
well conserved homolog in all phyla. 
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In deciding to perform phenotypic screening, one caution - that must be considered - is 
whether the phenotype observed is directly related to the gene's function or is indirectly related 
to the gene's function. The change in proton concentration intracellularly can impact various 
processes from DNA replication to protein stability. Therefore, when a mutant shows a 
phenotype of sensitivity to low pH, it cannot be assumed it is due directly to the protein's 
function, but must consider it could be related to the protein's interactions with other proteins 
that have a direct impact on intracellular pH maintenance or pH damage recovery systems. In the 
case of COG_2501 homologs in the Firmicutes phyla, the protein itself is annotated as an RNA 
binding protein based on similarity in sequence motif, but that should not alone have great 
impact on maintenance of intracellular proton concentration or DNA damage. However, all 
homologs in the Firmicutes phyla share an operon with recombination protein F, which is 
necessary to repair DNA damage. Without the homologous recombination pathway of DNA 
repair at a pH extreme to the particular bacteria, it will no longer be able to grow or survive. This 
is an example of an indirectly related phenotype where it is the protein's interaction with another 
protein that leads to the expression of a phenotype. 
The method of screening, solid or liquid phase, can streamline your screening process. 
For the oral microbiome, the majority of the screening is performed in liquid phase, which is 
beneficial since it provides quantitative data immediately. However, performing the screening in 
solid phase provides qualitative and physical data, which is extremely useful. The problem arises 
when you try to do solid phase with chemically defined media. Certain vitamins degrade above a 
temperature of 60 C. Therefore, I had to design a method to create solid phase chemically 
defined agar plates. Agar remains in liquid phase until 55 C. Therefore, the flask has to be placed 
in a hot water bath to maintain it at this temperature after autoclaving. The temperature sensitive 
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nutrients are added when the water bath temperature settles back to 55 C (Note: When you place 
a container of a higher temperature in water, it will increase the temperature of the water 
temporarily). 
When using interaction network databases, the networks presented must be evaluated 
carefully. For SSA_2372, the string database  presents multiple functional partners including 
DNA gyrase B, chromosomal initiation protein, DNA-directed RNA polymerase subunit delta, 
and DNA polymerase III subunit beta. This network would suggest that SSA_2372 is involved in 
DNA replication. The string database annotates it as being due to genomic context. However, 
when you look at the genomic context for SSA_2372, it is only adjacent to recombination protein 
F. When you continue data mining, it is discovered that the genes labeled as within the 
neighborhood and as appearing concurrently appears only in the model organism, E. coli.  Most 
times the data presented in databases like String will be based on only one bacterium, but it will 
present the data as if it were based on that particular species or genus. There needs to be better 
contextual relationships presented for these networks, and actual interaction data should be 
utilized such as from Intact or by data mining. 
Based on the genomic context of S. sanguinis SK36 and a microfluidic experiment 
performed by a collaborator (Meier et al), SSA_2372 is involved in some degree with the protein 
recombination protein F. For all bacteria in the phyla Firmicutes, the homologs, COG2501, are 
adjacent (2 to 5 AA apart) to recF. In a microchip array study with cDNA spotted in individual 
wells, recF as a bait expressed in a well interacted with the SP_2226 (Streptococcus pneumoniae 
TIGR4) protein solution. Since the cDNA is transcribed to RNA and translated to protein in the 
well, there is a potential that the SP_2226 interacted with both the DNA/RNA and protein of 
SP_2227, RecF.  
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Based on our data and the data mined, there is a great likelihood that our protein is a 
transcription factor or regulator of recombination protein F. The reason that I believe it is a 
regulator is because of its protein expression level.  Proteins in the cytosol that bind RNA or bind 
other proteins tend to be expressed in great abundance (30). However, transcription factors or 
other regulators tend to be expressed in low abundance. Our protein is expressed in the bottom 
10 to 25% of total proteins expressed in a bacterium (Table 6). However, its homolog which is 
known to bind RNA is expressed in the top 25% repeatedly (Table 6). Based on the microfluidics 
data of S. pneumoniae, its only interactor is recombination protein F after being screened against 
all proteins is only recF. Now these wells will contain both protein, cDNA, and RNA. Therefore, 
I cannot be certain at which stage SSA_2372 regulates its expression. Nevertheless, when 
dsDNA damage occurs in response to a high proton concentration without the presence or 
functionality of SSA_2372, the growth rate and cell yield is diminish significantly. There is 
another piece of information that suggests it is involved in the homologous recombination 
pathway. In Y2H, it bound PTS system IIA component (Table 5). PTS system IIA component 
whether cytosolic or membrane bound catalyzes the pathway that leads to the transcription and 
later translation of catabolic proteins. RecF requires ATP in its recFOR pathway in order to load 
recA to the dsDNA breaks. Therefore, it would make sense potentially that a protein involved in 
regulating recF expression would also be involved in metabolism. Since SSA_2372 has two 
binding domains that also increases the feasibility of it performing 2 functions (Table 3). 
 
 
 
 
 52 
 
Supplemental  
 
Supplemental Figure 1. BHI Agar Plate (pH7) Pinned with Streptococcus sanguinis SK36 
mutants. On these two plates, 95 mutants were pinned in quadruplicate, and the plate was 
incubated at 37 °C under microaerophilic conditions for 48 hours. 
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Supplemental Figure 2. Growth Curves of the S. sanguinis SK36 candidate mutants and 
control mutants in BHI broth at pH 5.4. 96 well plates were inoculated in pH specific media, 
and it was grown overnight under microaerophilic conditions. Optical density readings at 600nm 
were recorded every 10 minutes. 
 
R Code.  Statistical Tests performed to determine statistical significance were performed 
using R Studio and the following code.  
Eleventh<-read.csv(file.choose(),header = TRUE) 
Eleventh$X6y 
Eleventh$X6oxac 
sixy<-(Eleventh$X6y) 
sixy 
sixoxac<-(Eleventh$X6oxac) 
Eleventh$X5point4y 
Eleventh$X5point4oxac 
fivefoury<-(Eleventh$X5point4y) 
fivefoury 
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fivefouroxac<-(Eleventh$X5point4oxac) 
msixy<-mean(Eleventh$X6y) 
msixoxac<-mean(Eleventh$X6oxac) 
t.test(sixy, sixoxac, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level = 0.95) 
t.test(fivefoury, fivefouroxac, alternative = c("two.sided"), mu = 0, paired = FALSE, 
conf.level = 0.95) 
thirdtwenty<-read.csv(file.choose(),header = TRUE) 
thirdtwenty$X5pHoxac 
t.test(thirdtwenty$X5pHoxac, thirdtwenty$X5pHybcj, alternative = c("two.sided"), mu = 0, 
paired = FALSE, conf.level = 0.95) 
t.test(thirdtwenty$X5.5pHoxac, thirdtwenty$X5.5pHybcj, alternative = c("two.sided"), mu = 
0, paired = FALSE, conf.level = 0.95) 
t.test(thirdtwenty$X6pHoxac, thirdtwenty$X6pHybcj, alternative = c("two.sided"), mu = 0, 
paired = FALSE, conf.level = 0.95) 
msixy 
thirdtwenty$X6pHybcj 
sixy 
Ecoli<-read.csv(file.choose(),header = TRUE) 
t.test(Ecoli$X7pHoxac, Ecoli$X7pHybcj, alternative = c("two.sided"), mu = 0, paired = 
FALSE, conf.level = 0.95) 
t.test(Ecoli$X6pHoxac, Ecoli$X6pHybcj, alternative = c("two.sided"), mu = 0, paired = 
FALSE, conf.level = 0.95) 
t.test(Ecoli$X5pHoxac, Ecoli$X5pHybcj, alternative = c("two.sided"), mu = 0, paired = 
FALSE, conf.level = 0.95) 
 
June<-read.csv(file.choose(),header = TRUE) 
May<-read.csv(file.choose(), header=TRUE) 
June$sixsk36 
May$sixsk36 
fourteen<-(June$six1480 + May$six1480) 
meanfour<-((fourteen)/(2)) 
meanfour 
twentythree<-(June$six2372+May$six2372) 
meanthree<-((twentythree)/(2)) 
meanthree 
sk36<-(June$sixsk36 + May$sixsk36) 
meansk36<-((sk36)/(2)) 
t.test(meansk36, meanfour, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level = 
0.95) 
t.test(meansk36, meanthree, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level 
= 0.95) 
fifteen<-(June$six1507 + May$six1507) 
meanfif<-((fifteen)/(2)) 
meanfif 
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t.test(meansk36, meanfif, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level = 
0.95) 
t.test(meansk36, meanthree, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level 
= 0.99) 
t.test(meansk36, meanfour, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level = 
0.99) 
meansk36 
June$sevenSK36 
May$sevenSK36 
SK36neutral<-(June$sevenSK36+May$sevenSK36) 
meansk36neu<-((SK36neutral)/(2)) 
meansk36neu 
June$seven1507 
May$seven1507 
fifneutral<-(June$seven1507+May$seven1507) 
meanfifneu<-((fifneutral)/(2)) 
meanfifneu 
June$seven2372 
May$seven2372 
twothreeneutral<-(June$seven2372+May$seven2372) 
meantwothreeneu<-((twothreeneutral)/(2)) 
meantwothreeneu 
Bacillus<-read.csv(file.choose(),header = TRUE) 
Bacillus 
t.test(Bacillus$X5.5pHbs168, Bacillus$X5.5pHbsx, alternative = c("two.sided"), mu = 0, 
paired = FALSE, conf.level = 0.95) 
t.test(Bacillus$X6pHbs168, Bacillus$X6pHbsx, alternative = c("two.sided"), mu = 0, paired = 
FALSE, conf.level = 0.95) 
t.test(Bacillus$X5pHbs168, Bacillus$X5pHbsx, alternative = c("two.sided"), mu = 0, paired = 
FALSE, conf.level = 0.95) 
t.test(Bacillus$X5pHbs168, Bacillus$X5pHbsx, alternative = c("two.sided"), mu = 0, paired = 
FALSE, conf.level = 0.99) 
t.test(Bacillus$X7pHbs168, Bacillus$X7pHbsx, alternative = c("two.sided"), mu = 0, paired = 
FALSE, conf.level = 0.95) 
 
 
 
 
 
 
 56 
 
References 
 
1. Foundation N. Homology. Hoboken: Hoboken : Wiley; 2008.  
2. Inkpen SA, Doolittle WF. Molecular Phylogenetics and the Perennial Problem of Homology. J 
Mol Evol. 2016.  
3. Shahbaaz M, Bisetty K, Ahmad F, Hassan MI. Current Advances in the Identification and 
Characterization of Putative Drug and Vaccine Targets in the Bacterial Genomes. Current Topics 
in Medicinal Chemistry. 2016;16:1040-1069.  
4. Ijaq J, Chandrasekharan M, Poddar R, Bethi N, Sundararajan VS. Annotation and curation of 
uncharacterized proteins- challenges. Frontiers in genetics. 2015;6:119.  
5. Galperin MY, Koonin EV. 'Conserved hypothetical' proteins: prioritization of targets for 
experimental study. Nucleic Acids Res. 2004;32:5452.  
6. Pommerville JC, author. Fundamentals of Microbiology. Body Systems Edition. Third edition, 
Body systems edition.. ed. Burlington, MA : Jones & Bartlett Learning; 2016.  
7. Williams NH. DNA Hydrolysis: Mechanism and Reactivity. Nucleic Acids and Molecular 
Biology. 2004;13:3-17.  
8. Kidane D, Sanchez H, Alonso JC, Graumann PL. Visualization of DNA double‐ strand break 
repair in live bacteria reveals dynamic recruitment of Bacillus subtilis RecF, RecO and RecN 
proteins to distinct sites on the nucleoids. Mol Microbiol. 2004;52:1627-1639.  
9. Malacinski GM. Essentials of Molecular Biology. 4th ed.. ed. Boston: Boston : Jones and 
Bartlett; 2003.  
10. Vaughan P. DNA Repair Protocols Prokaryotic Systems. Totowa: Totowa : Humana Press; 
2000.  
 57 
 
11. Lund P, Tramonti A, De Biase D. Coping with low p H : molecular strategies in 
neutralophilic bacteria. FEMS Microbiol Rev. 2014;38: 
12. Marsh P. Oral Microbiology. Washington, D.C.: Washington, D.C. : American Society for 
Microbiology; 1980. 
13. Xu P, Ge X, Chen L, et al. Genome-wide essential gene identification in Streptococcus 
sanguinis. Scientific Reports. 2011;1. 
14. Powell S, Forslund K, Szklarczyk D, et al. eggNOG v4.0: nested orthology inference across 
3686 organisms. Nucleic Acids Res. 2014;42:D231. 
15. Sievers F, Wilm A, Dineen D, et al. Fast, scalable generation of high‐ quality protein 
multiple sequence alignments using Clustal Omega. Molecular Systems Biology. 2011;7 
16. Letunic I, Bork P. Interactive tree of life (iTOL) v3: an online tool for the display and 
annotation of phylogenetic and other trees. Nucleic Acids Res. 2016;44:W242. 
17. Wang M, Herrmann CJ, Simonovic M, Szklarczyk D, Mering C. Version 4.0 of PaxDb: 
Protein abundance data, integrated across model organisms, tissues, and cell‐lines. Proteomics. 
2015;15:3163-3168. 
18. Bazzoli A, Tettamanzi AGB, Zhang Y. Computational Protein Design and Large-Scale 
Assessment by I- TASSER Structure Assembly Simulations. J Mol Biol. 2011;407:764-776. 
19. Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I- TASSER Suite: protein structure 
and function prediction. Nature Methods. 2014;12:7. 
20. Yang J, Zhang Y. I- TASSER server: new development for protein structure and function 
predictions. Nucleic Acids Res. 2015;43:W174. 
21. Wang S, Li W, Liu S, Xu J. RaptorX-Property: a web server for protein structure property 
prediction. Nucleic Acids Res. 2016;44:W430. 
 58 
 
22. Federhen S. The NCBI Taxonomy database. Nucleic Acids Res. 2012;40:D136. 
23. Gandrud C. Reproducible Research with R and RStudio. Second edition.. ed. Boca Raton : 
CRC Press, Taylor & Francis Group; 2015. 
24. Schumacker R. Understanding Statistics using R. New York, NY : Springer New York : 
Imprint: Springer; 2013. 
25. Aravind L, Koonin EV. Novel Predicted RNA-Binding Domains Associated with the 
Translation Machinery. J Mol Evol. 1999;48:291-302. 
26. Jiang M, Sullivan SM, Walker AK, Strahler JR, Andrews PC, Maddock JR. Identification of 
Novel Escherichia coli Ribosome-Associated Proteins Using Isobaric Tags and 
Multidimensional Protein Identification Techniques. The Journal of Bacteriology. 
2007;189:3434. 
27. Martin E. UniProt. Oxford University Press; 2009 
28. intact. Oxford University Press; 2008. 
29. Overmars L, Kerkhoven R, Siezen RJ, Francke C. MGcV: the microbial genomic context 
viewer for comparative genome analysis. BMC Genomics. 2013;14:209-209. 
30. Ishihama Y, Schmidt T, Rappsilber J, et al. Protein abundance profiling of the Escherichia 
coli cytosol. BMC Genomics. 2008;9:102-102. 
 
 
 
 
 
 
 59 
 
VITA 
Ayana Scott-Elliston was born on January 31, 1988 in Queens, NY. She graduated from Maggie 
L. Walker Governor’s School for Government & International Studies in Richmond, VA in 
2006. She received her Bachelor of Science in Biochemistry with a Minor in Classical Studies & 
Dance from the University of North Carolina at Greensboro in 2011.  
